CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-12 | Breitfeld Philip P. Director | Shares withheld for taxes | −3,562 | $7.51 | $27K | 14,638 |
| 2022-10-12 | Breitfeld Philip P. Director | Option exercise · Option to purchase Common Stock | −8,333 | 0 | ||
| 2022-10-12 | TOBIN SCOTT R Director | Option exercise | +10,000 | $3.21 | $32K | 30,000 |
| 2022-10-12 | TOBIN SCOTT R Director | Option exercise · Stock Options | −10,000 | 0 | ||
| 2021-11-05 | Brainin Robert Lawrence Director | Grant or award · Option to purchase Common Stock | +9,901 | $10.10 | $100K | 17,933 |
| 2021-11-05 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +8,045 | $10.10 | $81K | 8,045 |
| 2021-11-05 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +13,614 | $10.10 | $138K | 13,614 |
| 2021-11-05 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +8,045 | $10.10 | $81K | 8,045 |
| 2021-11-05 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +18,564 | $10.10 | $187K | 18,564 |
| 2021-11-05 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +14,851 | $10.10 | $150K | 14,851 |
| 2021-10-15 | SIDRANSKY DAVID Director | Option exercise | +16,667 | $1.59 | $27K | 764,901 |
| 2021-10-15 | SIDRANSKY DAVID Director | Shares withheld for taxes | +2,629 | $10.08 | $27K | 762,272 |
| 2021-10-15 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +16,667 | 0 | ||
| 2021-10-12 | TOBIN SCOTT R Director | Option exercise | +10,000 | $1.59 | $16K | 20,000 |
| 2021-10-12 | TOBIN SCOTT R Director | Option exercise · Stock Options | −10,000 | 0 | ||
| 2021-03-23 | Breitfeld Philip P. Director | Option exercise | +4,167 | $3.65 | $15K | 4,167 |
| 2021-03-23 | Breitfeld Philip P. Director | Shares withheld for taxes | −1,340 | $11.35 | $15K | 2,827 |
| 2021-03-23 | Breitfeld Philip P. Director | Option exercise · Option to purchase Common Stock | −4,167 | 0 | ||
| 2021-01-19 | Poliakoff Abba David Director | Option exercise | +10,000 | $1.59 | $16K | 70,147 |
| 2021-01-19 | Poliakoff Abba David Director | Option exercise | +10,000 | $3.21 | $32K | 80,147 |
Page 5 of 20 · 398 trades